Global Male Infertility Market Size To Worth USD 5.34 Billion By 2033 | CAGR of 3.49%

Advertisement

The Global Male Infertility Market Size was Valued at USD 3.79 Billion in 2023 and the Worldwide Male Infertility Market Size is Expected to Reach USD 5.34 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Bayer Healthcare, Andrology Solutions, Endo International plc., Parallabs Ltd., MERCK KGaA, Aytu BioScience, Inc., Cadila Healthcare Ltd., Halotech DNA SL, EMD Sereno, Inc., Zydus Lifesciences Limited, Cryolab Ltd., Sanofi, SCSA Diagnostics, Inc., Vitrolife, Intas Pharmaceuticals Ltd., and Other key vendors.

New York, United States, April 18, 2024 (GLOBE NEWSWIRE) — The Global Male Infertility Market Size is to Grow from USD 3.79 Billion in 2023 to USD 5.34 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 3.49% during projected period.


Advertisement

Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4046           

Male infertility is a disorder in which a guy is unable to conceive a female partner due to issues with his reproductive system. It is frequently associated with issues with sperm production, quality, and delivery. According to the world health organization (WHO), infertility is defined as the failure to conceive after 12 months or more of regular unprotected sexual intercourse. Male infertility can be caused by low sperm count, poor sperm shape or motility, hormonal imbalances, hereditary factors, and particular medical conditions such as varicocele. Male infertility can be caused by a variety of lifestyle factors, including excessive alcohol use, smoking, drug use, and obesity. The global male infertility market is expected to grow due to technological advancements, high adoption of assisted reproductive technology, and rising incidence of diseases like uneven morphology, low sperm concentration, and delayed motility. Factors like alcohol consumption, smoking, obesity, stress, and lifestyle changes also contribute to the market. However, the global male infertility market is hindered by high treatment costs and limited insurance coverage, affecting both the general population and healthcare professionals. Hence, these factors may impede the market growth of the global male infertility market during the forecast period.

Browse key industry insights spread across 200 pages with 110 Market data tables and figures & charts from the report on the “Global Male Infertility Market Size, Share, and COVID-19 Impact Analysis, By Test (DNA Fragmentation Technique, Oxidative Stress Analysis), By Treatment (Assisted Reproductive Technology, Varicocele Surgery, Medication), By End User (Hospitals & Clinics, Fertility Centers, Research Institutes, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.”

Buy Now Full Report: https://www.sphericalinsights.com/checkout/4046

The DNA fragmentation segment is anticipated to hold the greatest share of the global male infertility market during the projected timeframe.    
On the basis of test, the global male infertility market is divided into DNA fragmentation technique and oxidative stress analysis. Among these, the DNA fragmentation segment is anticipated to hold the greatest share of the global male infertility market during the projected timeframe. The growth can be attributed to the DNA fragmentation techniques used to analyze the integrity of sperm DNA.

The assisted reproductive technology segment is predicted to grow at the fastest pace in the global male infertility market during the estimated period.
On the basis of treatment, the global male infertility market is divided into assisted reproductive technology, varicocele surgery, and medication. Among these, the assisted reproductive technology segment is predicted to grow at the fastest pace in the global male infertility market during the estimated period. The segmental growth can be attributed to the technology and techniques that address a broad range of infertility treatments, providing solutions for males with issues such as low sperm count, poor sperm content, and poor motility.

The fertility centers segment is predicted to hold the greatest share of the global male infertility market during the estimated period.
On the basis of end user, the global male infertility market is divided into hospitals & clinics, fertility centers, research institutes, and others. Among these, the fertility centers segment is predicted to hold the greatest share of the global male infertility market during the estimated period. The segmental growth can be attributed to these centers being committed to providing an extensive range of services suited to individuals and couples dealing with reproductive concerns.

Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/4046

Europe is expected to hold the greatest share of the global male infertility market over the forecast period.

Europe is expected to hold the greatest share of the global male infertility market over the forecast period. The availability of well-equipped and advanced fertility clinics, greater usage of more expensive treatments, improved diagnostic and treatment coverage, and high level of understanding. Healthcare spending and the availability of well-established healthcare infrastructure are significant factors driving regional market growth. The senior population, diseases, and acceptance of minimally invasive procedures are all driving growth in this region’s fertility industry. The region’s advanced healthcare infrastructure, combined with shifting socio-cultural dynamics, has resulted in more understanding and acceptance of male infertility, driving more individuals and couples to seek treatment.

North America is predicted to grow at the fastest pace in the global male infertility market during the projected timeframe. The regional growth can be attributed to posterity health, offering technology-enabled male fertility services, which is expected to drive market growth due to the growing elderly population and improved healthcare facilities.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the global male infertility market include Bayer Healthcare, Andrology Solutions, Endo International plc., Parallabs Ltd., MERCK KGaA, Aytu BioScience, Inc., Cadila Healthcare Ltd., Halotech DNA SL, EMD Sereno, Inc., Zydus Lifesciences Limited, Cryolab Ltd., Sanofi, SCSA Diagnostics, Inc., Vitrolife, Intas Pharmaceuticals Ltd., Others.

Get Discount At @ https://www.sphericalinsights.com/request-discount/4046

Recent Developments

  • In November 2022, a new male infertility clinic has opened by Sidra Medicine as part of its expansion into the private reproductive health services market in Qatar. With the opening of the new male infertility clinic, Sirda Medicine is now equipped to provide couples with all-encompassing medical and surgical care. 

Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global male infertility market based on the below-mentioned segments:

Global Male Infertility Market, By Test

  • DNA Fragmentation Technique
  • Oxidative Stress Analysis

Global Male Infertility Market, By Treatment

  • Assisted Reproductive Technology
  • Varicocele Surgery
  • Medication

Global Male Infertility Market, By End User

  • Hospitals & Clinics
  • Fertility Centers
  • Research Institutes
  • Others

Global Male Infertility Market, Regional Analysis

  • North America
    • US
    • Canadas
    • Mexico
  • Europe
    • Germany
    • Uk
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Browse Related Reports

Global Smart Syringes Market Size, Share, and COVID-19 Impact Analysis, By Product (Auto Disable Syringes, Active Safety Syringes, Passive Safety Syringes), By Application (Drug Delivery, Vaccination, Blood Specimen Collection), By End User (Hospitals & HMOs, Diabetic patients, Psychiatrists, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

Global Cytotoxic Drugs Market Size, Share, And Covid-19 Impact Analysis, By Type (Branded, Generic), By Drug Type (Alkylating Agents, Antimetabolites, Antitumor Antibiotics, Plant Alkaloids), By Route of Administration (Oral, Parenteral), By Application (Lung Cancer, Breast Cancer, Pancreatic Cancer, Prostate Cancer, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, And Africa), Analysis and Forecast 2023 – 2033

Global Testosterone Replacement Therapy Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Injectables, Topicals, Others), By Active Ingredient Type (Testosterone, Methyl Testosterone, Testosterone Undecanoate, Testosterone Enanthate, Testosterone Cypionate), By End User (Hospitals, Clinics, Other), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

Global Electronic Health Records Market Size, Share, and COVID-19 Impact Analysis, By Product (On-Premise Software, & Cloud Based Software), By Application (Clinical Application, Healthcare Financing, Others), By End User (Hospitals, Clinics), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company’s mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: [email protected], [email protected]

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.